These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9593123)

  • 1. A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type beta-lactamases.
    Blázquez J; Negri MC; Morosini MI; Gómez-Gómez JM; Baquero F
    Antimicrob Agents Chemother; 1998 May; 42(5):1042-4. PubMed ID: 9593123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detrimental effect of the combination of R164S with G238S in TEM-1 beta-lactamase on the extended-spectrum activity conferred by each single mutation.
    Giakkoupi P; Tzelepi E; Tassios PT; Legakis NJ; Tzouvelekis LS
    J Antimicrob Chemother; 2000 Jan; 45(1):101-4. PubMed ID: 10629019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.
    Giakkoupi P; Hujer AM; Miriagou V; Tzelepi E; Bonomo RA; Tzouvelekis LS
    FEMS Microbiol Lett; 2001 Jul; 201(1):37-40. PubMed ID: 11445164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
    Giakkoupi P; Tzelepi E; Legakis NJ; Tzouvelekis LS
    J Antimicrob Chemother; 1999 Jan; 43(1):23-9. PubMed ID: 10381097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate.
    Sirot D; Recule C; Chaibi EB; Bret L; Croize J; Chanal-Claris C; Labia R; Sirot J
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1322-5. PubMed ID: 9174192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
    Moland ES; Sanders CC; Thomson KS
    J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of mutant SHV-5 beta-lactamases constructed by substitution of isoleucine or valine for methionine at position 69.
    Giakkoupi P; Miriagou V; Gazouli M; Tzelepi E; Legakis NJ; Tzouvelekis LS
    Antimicrob Agents Chemother; 1998 May; 42(5):1281-3. PubMed ID: 9593168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitution of lysine at position 104 or 240 of TEM-1pTZ18R beta-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam.
    Sowek JA; Singer SB; Ohringer S; Malley MF; Dougherty TJ; Gougoutas JZ; Bush K
    Biochemistry; 1991 Apr; 30(13):3179-88. PubMed ID: 1901218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-lactamase characterization in Escherichia coli isolates with diminished susceptibility or resistance to extended-spectrum cephalosporins recovered from sick animals in Spain.
    Briñas L; Moreno MA; Teshager T; Zarazaga M; Sáenz Y; Porrero C; Dominguez L; Torres C
    Microb Drug Resist; 2003; 9(2):201-9. PubMed ID: 12820806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of naturally occurring extended-spectrum TEM beta-lactamase variants by fluctuating beta-lactam pressure.
    Blazquez J; Morosini MI; Negri MC; Baquero F
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2182-4. PubMed ID: 10898697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and genetic characteristics of TEM-29B, a novel extended spectrum beta-lactamase.
    Bou G; Martínez-Beltrán J; Cerveró G; Pérez-Díaz JC
    FEMS Microbiol Lett; 1999 May; 174(1):185-90. PubMed ID: 10234838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo selection of a complex mutant TEM (CMT) from an inhibitor-resistant TEM (IRT) during ceftazidime therapy.
    Jacquier H; Marcadé G; Raffoux E; Dombret H; Woerther PL; Donay JL; Arlet G; Cambau E
    J Antimicrob Chemother; 2013 Dec; 68(12):2792-6. PubMed ID: 23861309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta-lactamase with altered substrate specificity for aztreonam and ceftazidime.
    Cantu C; Huang W; Palzkill T
    J Biol Chem; 1996 Sep; 271(37):22538-45. PubMed ID: 8798421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM beta-lactamases.
    Blazquez J; Morosini MI; Negri MC; Gonzalez-Leiza M; Baquero F
    Antimicrob Agents Chemother; 1995 Jan; 39(1):145-9. PubMed ID: 7695296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New system based on site-directed mutagenesis for highly accurate comparison of resistance levels conferred by SHV beta-lactamases.
    Nüesch-Inderbinen MT; Hächler H; Kayser FH
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1726-30. PubMed ID: 7486909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Asp-179 mutations in TEMpUC19 beta-lactamase on susceptibility to beta-lactams.
    Vakulenko SB; Tóth M; Taibi P; Mobashery S; Lerner SA
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1878-80. PubMed ID: 7486939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal.
    Féria C; Ferreira E; Correia JD; Gonçalves J; Caniça M
    J Antimicrob Chemother; 2002 Jan; 49(1):77-85. PubMed ID: 11751770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of extended-spectrum activity in TEM beta-lactamases in hyper-mutable, mutS Escherichia coli.
    Ellington MJ; Livermore DM; Pitt TL; Hall LM; Woodford N
    Clin Microbiol Infect; 2006 Aug; 12(8):800-3. PubMed ID: 16842578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of various beta-lactam antibiotics and phenotypical methods for detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases.
    Bedenic B; Vranes J; Mihaljevic Lj; Tonkic M; Sviben M; Plecko V; Kalenic S
    J Chemother; 2007 Apr; 19(2):127-39. PubMed ID: 17434820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
    Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
    J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.